Up-to-Date Insights on COVID-19 Treatment

OVERVIEW:

The symposium will address effective and safe treatments for patients with positive results of direct SARS-CoV-2 viral testing having mild to moderate COVID-19 symptoms and who are at high risk for progression to severe COVID-19 producing systemic complications, including hospitalization or death.

Speaker: Dale W. Bratzler, DO, MPH

OBJECTIVES:

 Review the epidemiology of COVID-19

 Identify current antiviral treatments for COVID-19

 List the groups of patients recommended to take oral antiviral treatments for COVID-19

 Discuss effective communication with patients on the benefits of and safe use of antiviral medications to treat COVID-19

 Explain the benefits and side-effects of taking antiviral medications for COVID-19

 Discuss the considerations for use of antiviral medications in patients on other drugs and those with underlying health conditions

 Look to the future and answer the question: "What does endemic COVID-19 look like?"

Expiration Date: January 16, 2026

The AOA designates this activity for a maximum of 1.5 AOA Category 1-A Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by a medical educational grant from Pfizer, Inc.